AbbVie says it will acquire Allergan
MLex Summary: Chicago-based AbbVie said today it will acquire Dublin-based Allergan for an equity value of $63 billion. The transaction between the pharmaceutical companies is expected to close in early 2020....To view the full article, register now.
Already a subscriber? Click here to view full article